SoftMedx Healthcare Limited has issued its AGM circular outlining two key resolutions:
1. Share Issuance Mandate • Board seeking authority to issue up to 20% of the shares in issue (excluding treasury shares) as at the AGM date. • Current share capital: 2.14 billion shares. • Maximum new shares: 428.47 million before, or 21.42 million after, the proposed 20-for-1 share consolidation referenced in the 23 April 2026 circular.
2. Share Repurchase Mandate • Board requesting authority to buy back up to 10% of shares outstanding, equal to 214.23 million shares pre-consolidation or 10.71 million shares post-consolidation. • Repurchases will be funded with legally available cash and cancelled upon settlement. The company confirms no share repurchases have occurred in the past six months.
Key Meeting Details • AGM date and time: 27 May 2026, 11:00 a.m. • Venue: 20/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong. • Record date: Share transfer registration closes 21–27 May 2026 (both days inclusive); transfers must be lodged by 4:30 p.m. on 20 May 2026. • All resolutions will be voted on by poll; no shareholders are required to abstain.
Proxy Arrangements • Completed proxy forms must reach Tricor Investor Services Limited at Far East Finance Centre by 48 hours before the meeting. • Proxy submission does not preclude shareholders from attending and voting in person.
The Board recommends shareholders vote in favour of all resolutions, citing flexibility to raise capital or return funds to shareholders when market conditions permit.
Comments